UnknownNot Applicable

Needle-embedding Therapy Alleviates Depressive Symptoms and Resets the Function of Executive Control System in Subthreshold Depression People

China80 participantsStarted 2020-04-01

Plain-language summary

The main objective of this trial is to evaluate the effectiveness of treating subthreshold depression by needle-embedding therapy. On this basis, the investigators will discuss the mechanism of needle-embedding therapy improving executive function control system.

Who can participate

Age range18 Years – 30 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Applicants self-identifying with a diminished mood who * screened positive for subthreshold depressive symptoms (Centre for Epidemiological Studies Depression Scale (CES-D) ≥ 16; * were scheduled for a semistructural clinical interview (the Mini International Neuropsychiatric Interview, the MINI) conducted by specialists in psychiatry to diagnose whether they are SD； * were not currently receiving or had a plan to receive a psychotherapy for any kind of mental health problem； * had had no psychotherapy for any kind of mental health disorder in the past six months. Exclusion Criteria: patients had * antidepressant use * alcohol dependency * psychosis * recent suicidalrisk * significant cognitive impairment * recent bereavement * terminal illness on clinical grounds

What they're measuring

Change in depressive symptoms as assessed by Patient Health Questionnaire-9（PHQ-9）

Timeframe: Baseline and 6 weeks, 1-, 3-, 6- and 12-month follow-up

Trial details

NCT IDNCT04319562

SponsorGuangdong Provincial Hospital of Traditional Chinese Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-31

Contact for this trial

Wenbin Fu, MD

+8613808888626 fuwenbin@139.com

View on ClinicalTrials.gov More Subthreshold Depression trials